Krijzer F N, Schipper J, Tulp M T, Koopman P A
Department of Pharmacology, Duphar B.V., Weesp, The Netherlands.
J Neural Transm Gen Sect. 1989;78(1):73-87. doi: 10.1007/BF01247115.
The aim of this study was to investigate the effects of chronic administration of desimipramine (DMI) after 2, 7 or 20 mg/kg per day, administered by osmotic minipumps, on electrocortical activity and beta-adrenergic receptors in rat brain. Rats receiving DMI chronically show a dose- and time-dependent increase of electrocortical activity above 15 Hz as well as a dose- and time-dependent decrease below 15 Hz. Already after 3 days of treatment a clear effect on the electrocorticogram (ECoG) was seen. The maximal change in the ECoG was reached at the end of the study, after 24 days of treatment. After acute treatment (20 and 45 minutes after 2, 4 or 10 mg/kg i.p.) with DMI, a decrease of electrocortical activity is seen above 15 Hz. Thus the effect of acute DMI treatment on the ECoG is different from that of chronic treatment. In the same group of rats the effect of chronic DMI treatment on the beta-adrenergic receptor number was determined 24 hours after the last ECoG recording. The number of beta-adrenergic receptors was dose dependently reduced in the DMI-treated rats as determined by [3H]-dihydroalprenolol binding. There was no change in affinity (KD) of the ligand for the beta-receptor. This finding was corroborated by a decrease in the functional activity of the beta-adrenergic receptors, as determined by isoprenaline stimulated efflux of cyclic-AMP in cortex slices. These data indicate that chronic treatment with DMI, resulting in a down-regulation of the cortical beta-adrenergic system, is paralleled by pronounced effects on the ECoG of rats. The different ECoG profiles after chronic DMI treatment compared with acute treatment suggest that adaptive changes in the electrical brain activity continually develop during the chronic treatment with this antidepressant drug.
本研究旨在探讨通过渗透微型泵每日按2、7或20mg/kg剂量长期给予地昔帕明(DMI)对大鼠脑电皮质活动和β-肾上腺素能受体的影响。长期接受DMI的大鼠表现出15Hz以上电皮质活动呈剂量和时间依赖性增加,以及15Hz以下呈剂量和时间依赖性降低。治疗3天后,对脑电图(ECoG)的影响就已明显可见。在研究结束时,即治疗24天后,ECoG达到最大变化。用DMI进行急性治疗(腹腔注射2、4或10mg/kg后20和45分钟)后,15Hz以上的电皮质活动降低。因此,DMI急性治疗对ECoG的影响与慢性治疗不同。在同一组大鼠中,在最后一次ECoG记录24小时后测定慢性DMI治疗对β-肾上腺素能受体数量的影响。通过[3H]-二氢阿普洛尔结合测定,DMI治疗的大鼠中β-肾上腺素能受体数量呈剂量依赖性减少。配体与β-受体的亲和力(KD)没有变化。这一发现得到了β-肾上腺素能受体功能活性降低的证实,这是通过异丙肾上腺素刺激皮质切片中环磷酸腺苷的流出测定的。这些数据表明,DMI的慢性治疗导致皮质β-肾上腺素能系统下调,同时对大鼠的ECoG有显著影响。与急性治疗相比,慢性DMI治疗后不同的ECoG特征表明,在用这种抗抑郁药物进行慢性治疗期间,脑电活动的适应性变化持续发展。